Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer-Reference-Cited by-同舟云学术

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

Published:2023-12 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Orme Jacob J.^ORCID,Taza Fadi,De Sarkar Navonil,Tewari Alok K.,Arsalan Naqvi Syed,Riaz Irbaz B.,Childs Daniel S.,Omar Noha,Adra Nabil,Ashkar Ryan,Cheng Heather H.,Schweizer Michael T.,Sokolova Alexandra O.,Agarwal Neeraj,Barata Pedro,Sartor Oliver,Bastos Diogo,Smaletz Oren,Berchuck Jacob E.,McClure Heather,Taplin Mary-Ellen,Aggarwal Rahul,Sternberg Cora N.,Vlachostergios Panagiotis J.,Alva Ajjai S.,Mehra Niven,Nelson Peter S.,Hwang Justin,Dehm Scott M.,Shi Qian,Fleischmann Zoe,Sokol Ethan S.,Elliott Andrew,Huang Haojie,Bryce Alan,Marshall Catherine H.,Antonarakis Emmanuel S.^ORCID

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference34 articles.

1. The molecular taxonomy of primary prostate cancer;Abeshouse;Cell,2015

2. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy;Farmer;Nature,2005

3. Olaparib for metastatic castration-resistant prostate cancer;de Bono;N Engl J Med,2020

4. Rucaparib or physician’s choice in metastatic prostate cancer;Fizazi;N Engl J Med,2023

5. Niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer;Chi;J Clin Oncol,2023

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probes;Expert Review of Anticancer Therapy;2024-09-03

2. Durable benefit from poly(ADP-ribose) polymerase inhibitors in metastatic prostate cancer in routine practice: biomarker associations and implications for optimal clinical next-generation sequencing testing;ESMO Open;2024-09

3. Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis;European Urology Oncology;2024-05